Clémence Laperche

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 296 citations · Full text

Thrombosis, Dose-finding Phase 2, Cardiovascular Disease +10

Suture- or Plug-Based Large-Bore Arteriotomy Closure

Maarten P. van Wiechen, Didier Tchétché, Joris F. Ooms et al. · JACC: Cardiovascular Interventions · 2020 · 111 citations · Full text

Endovascular Technique, Vascular Malformation, Vascular Surgery +4

Transcatheter Treatment of Residual Significant Mitral Regurgitation Following TAVR

Guy Witberg, Pablo Codner, Uri Landes et al. · JACC: Cardiovascular Interventions · 2020 · 48 citations

Transcatheter Treatment, Valve Disease, Thoracic Surgery +4

Mid-term outcome of de novo lesions vs. in stent restenosis treated by intravascular lithotripsy procedures: Insights from the French Shock Initiative

Benjamin Honton, Janusz Lipiecki, Jacques Monségu et al. · International Journal of Cardiology · 2022 · 17 citations

Thrombosis, Mid-term Outcome, Endovascular Technique +9

Identification of a miRNA Based-Signature Associated with Acute Coronary Syndrome: Evidence from the FLORINF Study

Meyer Elbaz, Julien Faccini, Clémence Laperche et al. · Journal of Clinical Medicine · 2020 · 13 citations · Full text